Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Components of Equity-Based Compensation

The following table sets forth the components of our stock-based compensation and expected tax benefit for the three months ended March 31, 2023 and 2022 related to the plans in effect during the respective period:

	Three months ended March 31,
Stock-based compensation expense:	2023		2022
Restricted stock and restricted stock units (1)	$	15.8	$	7.4
Stock options	4.7		1.0
Incentive units	—		2.3
Total compensation expense	$	20.5	$	10.7
Expected tax benefit:
Restricted stock and restricted stock units	$	1.7	$	1.1
Stock options	0.2		0.1
Total expected tax benefit	$	1.9	$	1.2

(1)Higher expense for restricted stock and restricted stock units was primarily due to the full impact of our 2022 grants and the addition of our 2023 grants.

Schedule of Stock Options, Restricted Stock and Restricted Stock Units Activity

The following tables summarize the stock options activity for the three months ended March 31, 2023:

	Stock options
	Number of options	Weighted-average exercise price	Weighted-average remaining contractual term (in years)	Aggregate intrinsic value
Balances, January 1, 2023	11,094,868	$19.29	6.8	$—
Granted	—	$—
Forfeited	(33,334)	$22.00
Exercised	—	$—
Balances, March 31, 2023	11,061,534	$19.29	6.5	$—
Expected to vest as of March 31, 2023	5,554,871	$16.59	8.8	$—
Exercisable as of March 31, 2023	5,506,663	$22.00	4.3	$—

The following table summarizes the restricted stock and restricted stock units activity for the three months ended March 31, 2023:

	Restricted stock and Restricted stock units
	Number of shares	Weighted-average grant date fair value	Weighted-average remaining contractual term (in years)	Aggregate intrinsic value
Balances, January 1, 2023	7,007,683	$17.28	1.2	$85.9
Granted	4,680,926	$11.31
Forfeited	(159,140)	$17.68
Vested	(1,701,690)	$18.20
Balances, March 31, 2023	9,827,779	$14.21	1.6	$115.4